This information was published on 2026-03-02T08:14:51 for IP Right Registration Published.
| Field | Value |
| (210) | 2589833 (IR 1877250) |
| (220) |
19 Aug 2025
|
| (300) |
US, 21 Jul 2025, 99294479
US, 17 Jul 2025, 99289852 |
| (511) (510) |
Class 5
Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of oncologic diseases and disorders. Class 42 Pharmaceutical research and development; consulting services in the field of biotechnology; consulting services in the field of pharmaceutical research and development; medical research; medical research services in the field of cancer; medical research in the field of oncology; research and development of pharmaceuticals for the treatment of cancer; providing information about medical research in the field of cancer. Class 44 Medical information; providing information in the field of medicine; consulting services in the field of medical care; providing health information; providing health information in the field of cancer treatment; providing information in the field of cancer prevention, screening, diagnosis and treatment. |
| (540) | COHERUS ONCOLOGY |
| (550) | Word |
| (730) |
Coherus Oncology, Inc.
|
Find out more about publications on the About page.